Generate a tailored SOP for Dr. Kaye Williams. Improve your application with a focused, well-structured draft.
Professor Kaye Williams is a leader in the Hypoxia Therapeutics Group at the University of Manchester's Division of Pharmacy and Optometry. She joined the Department in November 1996, initially holding positions as a Research Associate and Research Fellow funded by the Medical Research Council, before achieving tenure in January 2006 and being promoted to Chair of Experimental Therapeutics and Imaging in August 2012. Her research primarily focuses on the tumor microenvironment, particularly the hypoxic conditions that significantly impact cancer treatment outcomes. Professor Williams leads preclinical imaging development at the Manchester Cancer Research Centre, playing a pivotal role in the development of image-derived biomarkers and their application in assessing therapeutic responses in oncology. She is involved in substantial collaborations and is a member of several professional bodies, contributing to advancing the field through her work and leadership roles, including the Deputy Director of CRUK RadNET Manchester. Professor Williams has received various awards, including the British Association for Cancer Research/AstraZeneca Frank Rose Young Scientist Award in 2005, recognizing her contributions to cancer research and education in the field.
University of Manchester • Manchester
Leading the Hypoxia Therapeutics Group, focusing on research and education in experimental therapeutics.
University of Manchester • Manchester
Managing the Division of Pharmacy and Optometry and overseeing research initiatives.
Includes MSc in Advanced Electrical Power Systems and MSc in Communications and Signal Processing.